132 related articles for article (PubMed ID: 32280028)
1. Diagnostic Performance of the Prostate Cancer Antigen 3 Test in Prostate Cancer: Systematic Review and Meta-analysis.
Lee D; Shim SR; Ahn ST; Oh MM; Moon DG; Park HS; Cheon J; Kim JW
Clin Genitourin Cancer; 2020 Oct; 18(5):402-408.e5. PubMed ID: 32280028
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis accuracy of PCA3 level in patients with prostate cancer: a systematic review with meta-analysis.
Qin Z; Yao J; Xu L; Xu Z; Ge Y; Zhou L; Zhao F; Jia R
Int Braz J Urol; 2020; 46(5):691-704. PubMed ID: 31961625
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of prostate cancer antigen 3 for detecting prostate cancer: a systematic review and meta-analysis.
Cui Y; Cao W; Li Q; Shen H; Liu C; Deng J; Xu J; Shao Q
Sci Rep; 2016 May; 6():25776. PubMed ID: 27161545
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of the PCA3 test for prostate cancer diagnosis: a systematic review and meta-analysis].
Ruiz-Aragón J; Márquez-Peláez S
Actas Urol Esp; 2010 Apr; 34(4):346-55. PubMed ID: 20470697
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of urine prostate cancer antigen 3 test using a cutoff value of 35 μg/L in patients with prostate cancer.
Hu B; Yang H; Yang H
Tumour Biol; 2014 Sep; 35(9):8573-80. PubMed ID: 24863945
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic value of miRNA-141 in prostate cancer: A systematic review and PRISMA-compliant meta-analysis.
Ye Y; Yuan XH; Wang JJ; Wang YC; Li SL
Medicine (Baltimore); 2020 May; 99(22):e19993. PubMed ID: 32481368
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer antigen 3 as a biomarker in the urine for prostate cancer diagnosis: a meta-analysis.
Xue WJ; Ying XL; Jiang JH; Xu YH
J Cancer Res Ther; 2014 Nov; 10 Suppl():C218-21. PubMed ID: 25450286
[TBL] [Abstract][Full Text] [Related]
8. Comparison of diagnostic efficacy by two urine PCA3 scores in prostate cancer patients undergoing repeat biopsies.
Jiang Z; Zhao Y; Tian Y
Minerva Urol Nefrol; 2019 Aug; 71(4):373-380. PubMed ID: 30203935
[TBL] [Abstract][Full Text] [Related]
9. Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients.
Merriel SWD; Pocock L; Gilbert E; Creavin S; Walter FM; Spencer A; Hamilton W
BMC Med; 2022 Feb; 20(1):54. PubMed ID: 35125113
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of prostate cancer antigen 3 (PCA3) prior to first prostate biopsy: A systematic review and meta-analysis.
Rodríguez SVM; García-Perdomo HA
Can Urol Assoc J; 2020 May; 14(5):E214-E219. PubMed ID: 31793864
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer antigen 3 test for prostate biopsy decision: a systematic review and meta analysis.
Luo Y; Gou X; Huang P; Mou C
Chin Med J (Engl); 2014; 127(9):1768-74. PubMed ID: 24791889
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of prostate cancer antigen 3 and the Prostate Health Index in detecting overall and clinically significant prostate cancer in men at first biopsy: A meta-analysis.
Jia W; Wu B; Shao Y; Cao X; Wang D
Int J Urol; 2021 Mar; 28(3):315-325. PubMed ID: 33336418
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
Sciarra A; Panebianco V; Cattarino S; Busetto GM; De Berardinis E; Ciccariello M; Gentile V; Salciccia S
BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
[TBL] [Abstract][Full Text] [Related]
14. The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance.
van Gils MP; Hessels D; van Hooij O; Jannink SA; Peelen WP; Hanssen SL; Witjes JA; Cornel EB; Karthaus HF; Smits GA; Dijkman GA; Mulders PF; Schalken JA
Clin Cancer Res; 2007 Feb; 13(3):939-43. PubMed ID: 17289888
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of prostate cancer gene 3 score in diagnosis among Chinese men with prostate cancer and benign prostatic hyperplasia.
Huang J; Reilly KH; Zhang HZ; Wang HB
BMC Urol; 2015 Dec; 15():118. PubMed ID: 26628213
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Performance of Radiolabeled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging in Newly Diagnosed Intermediate to High-Risk Prostate Cancer Patients: A Systematic Review and Meta-Analysis.
Kim SJ; Lee SW; Ha HK
Urol Int; 2019; 102(1):27-36. PubMed ID: 30269140
[TBL] [Abstract][Full Text] [Related]
17. Value of free/total prostate-specific antigen (f/t PSA) ratios for prostate cancer detection in patients with total serum prostate-specific antigen between 4 and 10 ng/mL: A meta-analysis.
Huang Y; Li ZZ; Huang YL; Song HJ; Wang YJ
Medicine (Baltimore); 2018 Mar; 97(13):e0249. PubMed ID: 29595681
[TBL] [Abstract][Full Text] [Related]
18. Combination of Prostate Cancer Antigen 3 and Prostate-Specific Antigen Improves Diagnostic Accuracy in Men at Risk of Prostate Cancer.
Cao L; Lee CH; Ning J; Handy BC; Wagar EA; Meng QH
Arch Pathol Lab Med; 2018 Sep; 142(9):1106-1112. PubMed ID: 29547000
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness review: prostate cancer antigen 3 testing for the diagnosis and management of prostate cancer.
Bradley LA; Palomaki GE; Gutman S; Samson D; Aronson N
J Urol; 2013 Aug; 190(2):389-98. PubMed ID: 23545099
[TBL] [Abstract][Full Text] [Related]
20. The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation.
Nicholson A; Mahon J; Boland A; Beale S; Dwan K; Fleeman N; Hockenhull J; Dundar Y
Health Technol Assess; 2015 Oct; 19(87):i-xxxi, 1-191. PubMed ID: 26507078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
